Publication:
Ultra-hypofractionation for node-positive prostate cancer: pushing boundaries and redefining standards.

Simple item page
cris.virtualsource.author-orcid693a84c1-f4d5-4094-a42b-311a5b909f6a
datacite.rightsmetadata.only
dc.contributor.authorLe Guévelou, Jennifer
dc.contributor.authorJeandin, Mathilde
dc.contributor.authorAngrisani, Antonio
dc.contributor.authorBosetti, Davide Giovanni
dc.contributor.authorShelan, Mohamed
dc.contributor.authorZilli, Thomas
dc.date.accessioned2025-05-19T12:43:13Z
dc.date.available2025-05-19T12:43:13Z
dc.date.issued2025-05-08
dc.description.abstractRadiotherapy is a cornerstone in the management of node-positive prostate cancer. Advances in imaging modalities and radiation therapy techniques have led to the evolution of treatment standards for this patient population. This review aims to explore the therapeutic advancements of the past decade, with a focus on the role of ultra-hypofractionated radiotherapy in node-positive prostate cancer.
dc.description.notePerspective = further contibution gemäss Liste Meddek, eb/19.5.2025
dc.description.sponsorshipClinic of Radiation Oncology
dc.identifier.pmid40341654
dc.identifier.publisherDOI10.1038/s41391-025-00976-7
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/210794
dc.language.isoen
dc.publisherSpringer Nature [academic journals on nature.com]
dc.relation.ispartofProstate Cancer and Prostatic Diseases
dc.relation.issn1476-5608
dc.relation.issn1365-7852
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleUltra-hypofractionation for node-positive prostate cancer: pushing boundaries and redefining standards.
dc.typearticle
dspace.entity.typePublication
oairecerif.author.affiliationClinic of Radiation Oncology
unibe.contributor.roleauthor
unibe.description.ispublishedinpress
unibe.refereedtrue
unibe.subtype.articlecontribution

Files

Collections

Publications